More NewsRead More
Merrimack Pharmaceuticals Reports Fourth Quarter 2014 Financial Results
February 26, 2015
Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients with Heregulin Positive Non-Small Cell Lung Cancer
February 19, 2015
Merrimack Pharmaceuticals Announces Timing of Fourth Quarter 2014 Investor Conference Call
February 12, 2015
Biotech Stocks Technical Review -- Merrimack Pharma, Orexigen Therapeutics, Alkermes, Galena Biopharma, and Synta Pharma
February 11, 2015
Merrimack Pharmaceuticals Names Birgit M. Schoeberl, Ph.D. as Head of Discovery Division and Announces the Addition of Ulrik B. Nielsen, Ph.D. to Its Board of Directors
January 22, 2015
Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the American Society of Clinical Oncology (ASCO) 2015 Gastrointestinal Cancers Symposium
January 20, 2015
Biggest Movers in Healthcare Stocks Now – MDCO KND CYH ICUI
March 18, 2015
Hottest Healthcare Stocks Now – RGEN ANAC BMRN HALO
March 13, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here